ATE549341T1 - Spiroketale - Google Patents
SpiroketaleInfo
- Publication number
- ATE549341T1 ATE549341T1 AT06840408T AT06840408T ATE549341T1 AT E549341 T1 ATE549341 T1 AT E549341T1 AT 06840408 T AT06840408 T AT 06840408T AT 06840408 T AT06840408 T AT 06840408T AT E549341 T1 ATE549341 T1 AT E549341T1
- Authority
- AT
- Austria
- Prior art keywords
- infections
- useful
- methods
- spiroketals
- spiroketal compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005907277A AU2005907277A0 (en) | 2005-12-23 | Spiroketals | |
| PCT/AU2006/002000 WO2007070984A1 (en) | 2005-12-23 | 2006-12-22 | Spiroketals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE549341T1 true ATE549341T1 (de) | 2012-03-15 |
Family
ID=38188191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06840408T ATE549341T1 (de) | 2005-12-23 | 2006-12-22 | Spiroketale |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8013012B2 (de) |
| EP (1) | EP1971608B1 (de) |
| JP (2) | JP5324922B2 (de) |
| CN (1) | CN101389632B (de) |
| AT (1) | ATE549341T1 (de) |
| AU (1) | AU2006326871B2 (de) |
| CA (1) | CA2634468C (de) |
| DK (1) | DK1971608T3 (de) |
| ES (1) | ES2386038T3 (de) |
| NZ (1) | NZ569403A (de) |
| PT (1) | PT1971608E (de) |
| WO (1) | WO2007070984A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006326871B2 (en) * | 2005-12-23 | 2011-09-15 | Ecobiotics Limited | Spiroketals |
| TW201011043A (en) | 2008-06-20 | 2010-03-16 | Chugai Pharmaceutical Co Ltd | Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives |
| TWI481422B (zh) * | 2010-02-26 | 2015-04-21 | Univ Kaohsiung Medical | 抑制皮膚色素沉著之組合物及其用途 |
| JP5733087B2 (ja) | 2011-07-29 | 2015-06-10 | 信越化学工業株式会社 | 室温湿気増粘型熱伝導性シリコーングリース組成物 |
| WO2015154064A2 (en) | 2014-04-04 | 2015-10-08 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| CN112094699B (zh) * | 2020-09-27 | 2023-03-28 | 广西壮族自治区林业科学研究院 | 一种樟树纯露的提取方法 |
| CN113875598B (zh) * | 2021-11-19 | 2022-10-18 | 宜宾学院 | 一种诱导半夏愈伤组织的方法及其专用培养基 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4845499A (en) * | 1998-06-29 | 2000-01-17 | Parker Hughes Institute | Synthetic spiroketal pyranes as potent anti-cancer agents |
| US6335364B1 (en) * | 1998-06-29 | 2002-01-01 | Parker Hughes Institute | Synthetic spiroketal pyranes as potent anti-cancer agents |
| US6069238A (en) * | 1998-09-30 | 2000-05-30 | Eli Lilly And Company | Spirocyclic C-glycosides |
| JP4168495B2 (ja) * | 1998-10-05 | 2008-10-22 | 三菱化学株式会社 | ４級アンモニウム塩の製造方法 |
| AU2006326871B2 (en) * | 2005-12-23 | 2011-09-15 | Ecobiotics Limited | Spiroketals |
-
2006
- 2006-12-22 AU AU2006326871A patent/AU2006326871B2/en active Active
- 2006-12-22 JP JP2008546040A patent/JP5324922B2/ja not_active Expired - Fee Related
- 2006-12-22 US US12/158,420 patent/US8013012B2/en active Active
- 2006-12-22 ES ES06840408T patent/ES2386038T3/es active Active
- 2006-12-22 AT AT06840408T patent/ATE549341T1/de active
- 2006-12-22 NZ NZ569403A patent/NZ569403A/en unknown
- 2006-12-22 CA CA2634468A patent/CA2634468C/en active Active
- 2006-12-22 EP EP06840408A patent/EP1971608B1/de active Active
- 2006-12-22 DK DK06840408.6T patent/DK1971608T3/da active
- 2006-12-22 CN CN2006800533527A patent/CN101389632B/zh active Active
- 2006-12-22 PT PT06840408T patent/PT1971608E/pt unknown
- 2006-12-22 WO PCT/AU2006/002000 patent/WO2007070984A1/en active Application Filing
-
2011
- 2011-08-11 US US13/208,210 patent/US8466194B2/en active Active
-
2013
- 2013-04-04 JP JP2013078139A patent/JP2013177393A/ja active Pending
- 2013-05-17 US US13/896,587 patent/US8680141B2/en active Active
-
2014
- 2014-03-21 US US14/221,629 patent/US8921414B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007070984A1 (en) | 2007-06-28 |
| US20130324596A1 (en) | 2013-12-05 |
| AU2006326871B2 (en) | 2011-09-15 |
| JP5324922B2 (ja) | 2013-10-23 |
| NZ569403A (en) | 2010-10-29 |
| US8680141B2 (en) | 2014-03-25 |
| EP1971608B1 (de) | 2012-03-14 |
| CA2634468A1 (en) | 2007-06-28 |
| CA2634468C (en) | 2014-10-07 |
| US20090082428A1 (en) | 2009-03-26 |
| JP2009520698A (ja) | 2009-05-28 |
| US20120034216A1 (en) | 2012-02-09 |
| PT1971608E (pt) | 2012-06-21 |
| EP1971608A1 (de) | 2008-09-24 |
| CN101389632A (zh) | 2009-03-18 |
| JP2013177393A (ja) | 2013-09-09 |
| US8921414B2 (en) | 2014-12-30 |
| AU2006326871A1 (en) | 2007-06-28 |
| US8466194B2 (en) | 2013-06-18 |
| US20140286938A1 (en) | 2014-09-25 |
| CN101389632B (zh) | 2013-02-06 |
| US8013012B2 (en) | 2011-09-06 |
| DK1971608T3 (da) | 2012-07-02 |
| EP1971608A4 (de) | 2010-02-24 |
| ES2386038T3 (es) | 2012-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301145I2 (nl) | Tirbanibulin | |
| EP2185514A4 (de) | Vinylarylderivate für mit entzündungen und dem immunsystem in zusammenhang stehende anwendungen | |
| SG170813A1 (en) | New compounds | |
| MX2009004047A (es) | Compuestos organicos. | |
| MX2009006846A (es) | Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias. | |
| UA101478C2 (ru) | Соединения, полезные как ингибиторы raf-киназы | |
| CY1110230T1 (el) | Αναστολεις γυρασης και χρησεις αυτων | |
| MX351401B (es) | Metodos y composiciones para el tratamiento de infecciones persistentes y cancer por inhibicion de la ruta de muerte celular programada (pd-1). | |
| MY177564A (en) | Anti-nr10 antibody and use thereof | |
| TN2010000096A1 (en) | Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors | |
| ATE548374T1 (de) | 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| MX2009009290A (es) | Compuestos activos en ppar. | |
| DK1971608T3 (da) | Spiroketaler | |
| WO2006104945A3 (en) | Hepatitis c therapies | |
| WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
| ATE510822T1 (de) | Kaliumkanalinhibitoren | |
| EA200800713A1 (ru) | Аморфные твёрдые дисперсии | |
| CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
| AU2010306647A8 (en) | Antimicrobial compounds and methods of making and using the same | |
| MX2008002294A (es) | Derivados de pirimidina sustituida. | |
| UA92593C2 (ru) | Лечение мастита энрофлоксацином | |
| CY1112746T1 (el) | Κρυοσυντηρηση ηπατοκυτταρων | |
| WO2006079068A3 (en) | Compositions and methods for studying and treating inflammatory diseases and disorders | |
| WO2005080549A3 (de) | Trioxacarcine und deren verwendung gegen infektionskrankheiten |